Quantification of PML-RAR alpha transcripts in acute promyelocytic leukaemia: explanation for the lack of sensitivity of RT-PCR for the detection of minimal residual disease and induction of the leukaemia-specific mRNA by alpha interferon - PubMed (original) (raw)

Quantification of PML-RAR alpha transcripts in acute promyelocytic leukaemia: explanation for the lack of sensitivity of RT-PCR for the detection of minimal residual disease and induction of the leukaemia-specific mRNA by alpha interferon

J R Seale et al. Br J Haematol. 1996 Oct.

Abstract

The RT-PCR technique for the identification of the PML-RAR alpha fusion mRNA is widely used for the detection of minimal residual in acute promyelocytic leukaemia (APL). A positive result after remission induction is highly predictive of early relapse, but the vast majority of patients have no detectable disease by this technique after chemotherapy consolidation, despite the fact that many later relapse. We report a quantitative PCR technique for the PML-RAR alpha cDNA which was used to show that less than 1000 PML-RAR alpha molecules are obtained from 1 microgram of diagnostic bone marrow RNA derived from approximately 1 million APL blasts. The lack of sensitivity of currently employed RT-PCR methods may therefore be explained by their poor yield of PML-RAR alpha cDNA. Minor modifications to the reverse transcription procedure improved this yield 3 fold. Furthermore, expression of the leukaemia-specific transcript increased by approximately one order of magnitude after incubation of the patient's cells for 24 h in vitro with 100 iu/ml alpha interferon.

PubMed Disclaimer

Comment in

Interferon enhanced minimal residual disease detection in acute promyelocytic leukaemia.
Palumbo GA, Romeo MA, Di Raimondo F, Giustolisi R. Palumbo GA, et al. Br J Haematol. 1997 Mar;96(4):876-7. Br J Haematol. 1997. PMID: 9074438 No abstract available.

Cited by

Phylogeography and population history of Atlantic mackerel (Scomber scombrus L.): a genealogical approach reveals genetic structuring among the eastern Atlantic stocks.
Nesbø CL, Rueness EK, Iversen SA, Skagen DW, Jakobsen KS. Nesbø CL, et al. Proc Biol Sci. 2000 Feb 7;267(1440):281-92. doi: 10.1098/rspb.2000.0998. Proc Biol Sci. 2000. PMID: 10714883 Free PMC article.
AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation.
Miyamoto T, Weissman IL, Akashi K. Miyamoto T, et al. Proc Natl Acad Sci U S A. 2000 Jun 20;97(13):7521-6. doi: 10.1073/pnas.97.13.7521. Proc Natl Acad Sci U S A. 2000. PMID: 10861016 Free PMC article.
Acute leukemia with promyelocytic features in PML/RARalpha transgenic mice.
He LZ, Tribioli C, Rivi R, Peruzzi D, Pelicci PG, Soares V, Cattoretti G, Pandolfi PP. He LZ, et al. Proc Natl Acad Sci U S A. 1997 May 13;94(10):5302-7. doi: 10.1073/pnas.94.10.5302. Proc Natl Acad Sci U S A. 1997. PMID: 9144232 Free PMC article.
Monitoring PML-RARalpha in acute promyelocytic leukemia.
Jurcic JG. Jurcic JG. Curr Oncol Rep. 2003 Sep;5(5):391-8. doi: 10.1007/s11912-003-0025-7. Curr Oncol Rep. 2003. PMID: 12895391 Review.

Quantification of PML-RAR alpha transcripts in acute promyelocytic leukaemia: explanation for the lack of sensitivity of RT-PCR for the detection of minimal residual disease and induction of the leukaemia-specific mRNA by alpha interferon - PubMed (original) (raw)